Technology from Cambridge headquartered superchip architect Arm is at the heart of a game-changing solution in bionics that ...
Cambridge Heartwear, a University of Cambridge spin-out and Made in Britain company, has been awarded a place on a national ...
Investment in the UK femtech sector has increased substantially over the last decade, with deal activity rising by more than 194 per cent, according to new research by law firm Mills & Reeve. Between ...
The London Stock Exchange is emptying, its companies lost to takeovers and to New York with almost nothing to replace them, writes Joe Renny. This is not a City problem. What Andy Burnham and his new ...
Law firm Birketts LLP has advised Fixfast Holdings Ltd on its acquisition of OSC Sales Ltd, a specialist supplier of ...
As the 2026 FIFA World Cup has unfolded across North America to a Messi end following Sunday's final, one of the most ...
Prologis has received planning committee consent to develop a further life science facility in Phase 2 of its investment ...
Infection control specialist Tristel, which is expanding across the US, has forecast an excellent set of results for the year ...
As the UK-FTA goes live, Jai Mallick, Managing Director, India, for global business development consultancy Intralink, outlines the opportunities it offers UK firms, particularly those in the ...
Healx, a Cambridge-based AI-powered, clinical-stage biotech company dedicated to rare diseases, reveals that the first patient has been dosed in HLX-4310, its proposed treatment for osteosarcoma - a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results